In the latest installment of our video series on the scientific and investment implications of COVID-19, Biotech Analyst Agustin Mohedas discusses how efforts to develop treatments and vaccines have accelerated innovation in health care. He also provides insight on the potential impact of certain states reopening their economies and what the timeline to develop an effective vaccine could look like.
- Efforts to generate vaccines for COVID-19 highlight the importance of innovation in health care and demonstrate how quickly new technologies can be developed.
- These efforts are also helping some companies accelerate their technological capabilities in a rapid and meaningful way. In addition, smaller companies with cutting-edge technology are starting to partner with pharmaceutical giants, which can ramp up manufacturing and distribution.
- A number of vaccines are currently being tested on healthy volunteers to determine the drugs' safety. While larger clinical trials will be needed to gauge the efficacy of these drugs, we expect some vaccines could be approved by early next year and become broadly available in the second half of 2021.
Subscribe for relevant insights delivered straight to your inbox